The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to Xlcare Pharmaceuticals Inc. to supply methocarbamol tablets. The single award contract has a potential value of $11.6M over a one year base period and four one-year options, with an end date for ordering of March 2025. Xlcare will provide methocarbamol tablets in 500mg and 750mg bottle sizes to the VA, DoD, Bureau of Prisons, Indian Health Service and Federal Health Care Center through their respective pharmaceutical prime vendor programs.
The originating pre-solicitation notice sought offers for an unrestricted contract to supply methocarbamol tablets in support of the VA pharmacy programs, including Consolidated Mail Outpatient Pharmacies and State Veterans Home Option 2. Estimated annual requirements ranged from approximately 15,000 to 96,000 bottles of 500mg and 750mg tablets. The notice specified requirements for bottle sizes of 100 and 500 tablets and anticipated distributing the awarded items through the VA and DoD pharmaceutical prime vendor systems. The purpose of the procurement is to ensure an uninterrupted supply of this pharmaceutical to serve VA and other federal agency healthcare needs over the potential five-year ordering period.
Generated 2/16/24, 9:24 AM